|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/85 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| C12N 9/64 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/40 | (2006.01) |
| (11) | Number of the document | 2738259 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14154967.5 |
| Date of filing the European patent application | 2012-02-24 | |
| (97) | Date of publication of the European application | 2014-06-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-03-10 |
| (30) | Number | Date | Country code |
| 201161446895 P | 2011-02-25 | US | |
| 201161497650 P | 2011-06-16 | US | |
| 201261595200 P | 2012-02-06 | US |
| (72) |
Macdonald, Lynn, US
Stevens, Sean, US
Murphy, Andrew J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | ADAM6 pelės |
| ADAM6 mice |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 15 | 289.00 EUR |
| 2027-02-24 |